You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory Renal Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Oct 17, 2022

Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

Completed
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • HyperAcute®-Renal (HAR) Immunotherapy
  • Iowa City, Iowa
  • +2 more
Apr 4, 2022

Clear Cell Renal Cell Carcinoma Trial in Duarte, Nashville (XmAb819)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • XmAb819
  • Duarte, California
  • +1 more
Jun 20, 2022

Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • CTX131
  • Nashville, Tennessee
    Research Site 1
Mar 21, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Renal Cell Carcinoma Trial in Shanghai (CCT301-38, CCT301-59)

Active, not recruiting
  • Renal Cell Carcinoma
  • CCT301-38
  • CCT301-59
  • Shanghai, Shanghai, China
    Shanghai Public Health Clinical Center
Oct 19, 2021

Renal Cell Carcinoma Trial in United States (LBH589)

Completed
Has Results
  • Renal Cell Carcinoma
  • Fort Myers, Florida
  • +9 more
Oct 26, 2021

Cancer, Solid Tumor, Melanoma Trial in United States (ST-067)

Recruiting
  • Cancer
  • +7 more
  • ST-067
  • Scottsdale, Arizona
  • +3 more
Mar 21, 2022

Malignant Melanoma, NSCLC, Renal Cell Cancer Trial in United Kingdom (ImmuniCell®)

Terminated
  • Malignant Melanoma
  • +2 more
  • ImmuniCell®
  • Cardiff, United Kingdom
  • +6 more
Mar 8, 2022

Renal Cell Carcinoma Trial in Philadelphia (drug, genetic, other, procedure)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Brivanib alaninate
  • +5 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 18, 2021

Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

Completed
  • Prostate Cancer
  • +6 more
  • MGA271
  • Los Angeles, California
  • +11 more
Feb 4, 2022

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

    Recruiting
    • Advanced Differentiated Thyroid Gland Carcinoma
    • +102 more
    • Cabozantinib S-malate
    • Nivolumab
    • Chicago, Illinois
    • +2 more
    Apr 5, 2022

    Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

    Available
    • Clear Cell Renal Cell Carcinoma
    • 89Zr-DFO-girentuximab
    • Los Angeles, California
      UCLA
    Oct 12, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 28, 2023

    First-line Treatment of Non-clear Renal Cell Carcinoma Trial (Fruquintinib combined with Serplulimab)

    Not yet recruiting
    • First-line Treatment of Non-clear Renal Cell Carcinoma
    • Fruquintinib combined with Serplulimab
    • (no location specified)
    Apr 16, 2023

    Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

    Recruiting
    • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
    • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
    • Shanghai, Shanghai, China
      Shanghai Renji Hospital
    Sep 12, 2023

    Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • +2 more
    • (no location specified)
    May 14, 2023

    Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +1 more
    Dec 14, 2022